Daw Park,Repatriation General Hospital

Name :

Daw Park,Repatriation General Hospital

Address  :

Daw Park

Town  :

Daw Park

State  :

South Australia

Country  :

AUSTRALIA

Post Code:

5041

Phone  :

61 8 8276 9666

Web URL  :


Description

Repatriation General Hospital RGH is a 300 bed acute care public hospital specialising in the care of older people and veterans The hospital provides a range of general medical and surgical services to people living in Adelaide RGH offers high quality integrated care from the acute stages through to rehabilitation

RGH is home to Rehabilitation amp Therapy Services a worldclass facility purposebuilt for rehabilitation It is also home to the Daw House Hospice renowned for quality palliative care

Through a number of statewide and specialist programs among them cardiology oncology urology and radiology it also services rural Adelaide and interstate regions

Established in 1942 RGH has forged strong affiliations with a number of research facilities some of which have colocated with the hospital It also has solid teaching foundations in all health disciplines with a range of educational institutes including Flinders University of South Australia

The hospitals mission is to provide highest quality patient care excellence in service promote top quality teaching and research respect and value our staff encourage innovation and continual improvement in meeting the needs of our community meet the special needs of the veteran community and work collaboratively with other health and aged care providers to enhance the health of the community of southern Adelaide


Lifesaving surgery for 40 patients

EIGHTEEN adults and 22 children will receive lifesaving heart surgery when a team from Operation Open Heart visits the Colonial War Memorial Hospital this week The visit will be coordinated by the Sydney Adventist Hospital in Australia which has already done the same on more than 80 trips around the world resulting in more than 2000 surgeries ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More